07:00 , Aug 31, 2009 |  BioCentury  |  Finance

Ebb & Flow

Retail investors got carried away last week on a rumor that Human Genome Sciences Inc. (NASDAQ:HGSI) would be acquired by partner GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) for $30 a share. On Tuesday, the stock hit a...
07:00 , Aug 10, 2009 |  BioCentury  |  Finance

Hope springs eternal

In a turn of events that could hardly have been imagined even a couple of months ago, some biotech bankers, VCs and companies are prepping for the return of an IPO market. The most optimistic...
07:00 , Aug 3, 2009 |  BC Week In Review  |  Financial News

BioQuanta financial update

BioQuanta listed its securities on NYSE Euronext under the symbol "MLBQA." BioQuanta, which closed Friday at EUR4.43, has 2.5 million shares outstanding. BioQuanta Corp. (Euronext:MLBQA), Aurora, Colo.   Business: ADMET, Computational chemistry/biology   Date announced:...
07:00 , Aug 3, 2009 |  BioCentury  |  Finance

Ebb & Flow

Cumberland Pharmaceuticals Inc. is hoping to capitalize on both the market upswing and the June FDA approval of its Caldolor IV ibuprofen to get an IPO out the door. The last substantial IPO was almost...